GSK
877 hedge funds and large institutions have $14.5B invested in GSK in 2025 Q2 according to their latest regulatory filings, with 110 funds opening new positions, 360 increasing their positions, 249 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 845 → 877 (+32)
2% more capital invested
Capital invested by funds: $14.2B → $14.5B (+$322M)
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
Holders
877
Holding in Top 10
9
Calls
$259M
Puts
$133M
Top Buyers
| 1 | +$134M | |
| 2 | +$118M | |
| 3 | +$97.2M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$79.2M |
| 5 |
Primecap Management
Pasadena,
California
|
+$77.5M |
Top Sellers
| 1 | -$106M | |
| 2 | -$101M | |
| 3 | -$57.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$57.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$44.4M |